Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | REZOLUTE INC RZLT | Nantahala Capital Management, LLC | 2,857,982 4.932% | -2,108,735 (-42.46%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | SENTI BIOSCIENCES INC SNTI | Nantahala Capital Management, LLC | 509,283 9.990% | 509,283 (New Position) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | TELA BIO INC TELA | Nantahala Capital Management, LLC | 3,974,326 9.990% | 2,059,200 (+107.52%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | VERASTEM INC VSTM | Nantahala Capital Management, LLC | 4,523,184 9.990% | 470,980 (+11.62%) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | ZEVRA THERAPEUTICS INC ZVRA | Nantahala Capital Management, LLC | 2,340,333 4.380% | -583,688 (-19.96%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | ALTISOURCE PORTFOLIO SOLUTIONS ASPS | Nantahala Capital Management, LLC | 266,036 7.820% | 266,036 (New Position) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | OPTINOSE INC OPTN | Nantahala Capital Management, LLC | 1,006,572 9.990% | -2,825 (-0.28%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | INSPIREMD INC NSPR | Nantahala Capital Management, LLC | 2,709,118 9.990% | 101,234 (+3.88%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | SURROZEN INC SRZN | Nantahala Capital Management, LLC | 338,930 9.990% | 3,899 (+1.16%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | SOLENO THERAPEUTICS INC PA SLNO | Nantahala Capital Management, LLC | 4,349,435 9.990% | 398,148 (+10.08%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | ANEBULO PHARMACEUTICALS INC CO ANEB | Nantahala Capital Management, LLC | 3,547,398 8.630% | 3,547,398 (New Position) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | APYX MED CORP COM APYX | Nantahala Capital Management, LLC | 3,493,235 9.990% | 3,493,235 (New Position) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | BLACKSKY TECHNOLOGY INC N BKSY | Nantahala Capital Management, LLC | 1,377,060 4.470% | -1,072,940 (-43.79%) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Nantahala Capital Management, LLC | 83,571 5.730% | -39,020 (-31.83%) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | CONNS INC CONNQ | Nantahala Capital Management, LLC | 1,389,773 5.580% | -874,805 (-38.63%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | DARIOHEALTH CORP COM DRIO | Nantahala Capital Management, LLC | 175,647 9.990% | 22,900 (+14.99%) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | ESTABLISHMENT LABS HLDGS INC C ESTA | Nantahala Capital Management, LLC | 1,682,688 6.100% | -676,453 (-28.67%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | EVENTBRITE INC EB | Nantahala Capital Management, LLC | 5,930,947 7.300% | 5,930,947 (New Position) | Filing History |
| 2025-02-03 4:47 pm Purchase | 2025-02-03 | 13D | EVOKE PHARMA INC EVOK | Nantahala Capital Management, LLC | 254,639 15.990% | 7 (+0.00%) | Filing History |
| 2024-12-20 4:32 pm Purchase | 2024-12-19 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Nantahala Capital Management, LLC | 1,087,914 9.990% | 71,979 (+7.09%) | Filing History |